Trump To Appoint Former GSK Executive Moncef Slaoui To Lead ‘Operation Warp Speed’ Search For Novel Coronavirus Vaccine

AP: Trump to name former pharma exec as vaccine czar
“President Donald Trump is set to name a former pharmaceutical executive to lead his administration’s all-out effort to produce and distribute a coronavirus vaccine by the end of the year. Moncef Slaoui, a former GlaxoSmithKline executive, will lead ‘Operation Warp Speed,’ Trump’s push to accelerate the vaccine development process for COVID-19, according to an administration official. Slaoui is to serve in a volunteer capacity, and will be assisted by Army Gen. Gustave Perna, the commander of United States Army Materiel Command. … ‘Operation Warp Speed’ is operating largely independently of the existing White House coronavirus task force, which is also shifting its focus toward vaccine development…” (Miller, 5/13).

Additional coverage of Slaoui’s expected appointment is available from The Hill, POLITICO, and Reuters.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.